PLK1 and cancer: Taken together, our results show that the expression of active PLK1 increased the cell motility, invasiveness, and tumorigenicity of cancer cells, whereas the expression of a catalytically inactive version or a version with a non-functional PBD blocked those abilities, indicating that PLK1 must have catalytic activity or protein-binding ability to amplify tumorigenic and metastatic progression.